# TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults

> **NCT06367634** · NA · UNKNOWN · sponsor: **Teoxane SA** · enrollment: 390 (estimated)

## Conditions studied

- Nasolabial Folds

## Interventions

- **DEVICE:** injection in NLF

## Key facts

- **NCT ID:** NCT06367634
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-19
- **Primary completion:** 2025-01
- **Final completion:** 2026-02
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367634, "TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06367634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*